Program

Friday, February 1, 2013

09:00

Registration and Distribution of Material

14:20

Opening Remarks Ian A. Greer, United Kingdom; Benjamin Brenner, Israel

14:30 - 15:45

HORMONAL THERAPY

Chairs: Sabine Eichinger-Hasenauer, Austria & Jacqueline Conard, France

14:30 

Observational studies of hormonal therapy and thrombosis: Methodological issues

Samy Suissa, Canada

14:55

Mechanisms of hormonal therapy related thrombosis 

Per Morten Sandset, Norway

15:20

Selected Oral Communications

1)       Venous thromboembolism in relation to in-vitro fertilization–An approach to determining the incidence and increase in risk in successful cycles; Rova K, Passmark H, Lindqvist PG; Sweden

2)       Risk of recurrent venous thromboembolism associated with female hormone intake – a prospective cohort study; Eischer L, Eichinger S, Kyrle PA; Austria

3)       Oral contraception and risk of venous thromboembolism within the first year following pregnancy; Petersen JF, Bergholt T, Nielsen AK, Lidegaard Ø, Paidas MJ, Løkkegaard ECL.; Denmark & USA

15:45

COFFEE BREAK

16:15 - 17:45

ARTERIAL THROMBOSIS

Chairs: Risto Kaaja, Finland & Emmanouil Papadakis, Greece

16:15

Thrombotic microangiopathy

Flora Peyvandi, Italy

16:40

Mechanical heart valves

Claire McLintock, New Zealand

17:05

Management of pregnant women with myeloproliferative neoplasms

Benjamin Brenner, Israel

17:30

Selected Oral Communications

1)       Gender aspects of fibrin clot structure in patients with type 1 diabetes mellitus; Tehrani S, Wallen NH, Elgue G, Majeed K, Henriksson P, Ågren A, Adamson U,  Lins PE, Jörneskog G,  Antovic A; Sweden

2)     Pregnancy and labour in patients with history of arterial thrombosis; Makatsariya AD, Bitsadze VO, Akinshina SV, Khizroeva DKh, Gadaeva ZK; Russia

17:45 - 19:00

POSTER SESSION

20:00 - 22:00

GET-TOGETHER RECEPTION

Saturday, February 2, 2013

08:30 - 10:00

PLACENTAL AND FETAL HAEMOSTASIS

Chairs: Beatriz E. Grand, Argentina & Paolo Simioni, Italy

08:30

Developmental haemostasis

Berend Isermann, Germany

08:55

Placental vascular lesions

Michal Kovo, Israel

09:20

Placenta-derived microparticles

Anat Aharon, Israel

09:45

Selected Oral Communications

1)      Effects of Low Molecular Heparin within the Uteroplacental Unit; Ismail SK, Norris L, Kelly L, Higgins JR; Ireland

2)      Inhibitor of PAI-1 prevents abortion in CBA/J x DBA/2 mice model; Marwan O, Ben Haroush S, Palzur E, Al-Roof Higazi A, Bornstein J; Israel

10:00

COFFEE BREAK

10:30 - 12:05

PREGNANCY COMPLICATIONS

Chairs: Saskia Middeldorp, the Netherlands & Michael Kupferminc, Israel

10:30

Thrombophilia and placenta-mediated complications

Marc A. Rodger, Canada

10:55

Antiphospholipid syndrome

Jean-Christophe Gris, France

11:20

Pathogenesis and management of peritpartum calamities (DIC and AFE)

Marcel Levi, the Netherlands

11:45

Selected Oral Communications

1)      Prevention of pregnancy loss in carriers of thrombophilia: The OTTILIA study; Grandone E, Villani M, De Stefano V, Ageno W,  Falasca A, Puggina P, Tranquilli A, Martinelli P, Margaglione M; Italy

2)      Low Molecular Weight Heparin in Recurrent Pregnancy Loss – Results of the ETHIG II Study; Schleussner E, Kamin G, Seeliger G, Rogenhofer N, Toth B for the ETHIG Investigator Group; Germany

3)      ALIFE2 Study: Call for partipation; Middeldorp S; the Netherlands

12:05 – 13:55

LUNCH BREAK

12:35 – 13:55

LUNCH SYMPOSIUM

Management of Pregnancy Complications

Chairs: Benjamin Brenner, Israel & Jean-Christophe Gris, France

12:35

Epidemiology of preeclampsia

Jean-Christophe Gris, France

12:50

Antithrombotics for pregnancy complications

Ian A. Greer, United Kingdom

13:05

Prevention of maternal and perinatal complications by enoxaparin in women with previous severe preeclampsia

Bassam Haddad, France

13:20

Global tests of coagulation in pregnancy

Paolo Simioni, Italy

13:35

Round Table

13:55 - 15:20

NEONATAL HAEMOSTASIS

Chairs: Silvia Hoirisch-Clapauch, Brazil & Simcha Yagel, Israel

13:55

Intraventricular hemorrhage

Gili Kenet, Israel

14:20

Neonatal thrombosis

Ulrike Nowak-Göttl, Germany

14:45

Neonatal alloimmune thrombocytopenia

Ulrich Sachs, Germany

15:10

Selected Oral Communications

1)      Correlation between isolated fetal cerebral ventriculomegaly and fetal and neonatal alloimmune thrombocytopenia; Martillotti G, Rypens F, David M, Catalfamo N, Désilet V, Dubé J, Taillefer C, Lachance C, Audibert F; Canada

15:20

COFFEE BREAK

15:50 - 17:25

BLEEDING IN WOMEN

Chairs: Rochelle Winikoff, Canada & Grigoris T. Gerotziafas, France

15:50

Recent advances in the management of ITP

Roberto Stasi, United Kingdom

16:15

Von Willebrand Disease: pathogenesis and management

Francesco Rodeghiero, Italy

16:40

Post-partum hemorrhage

Alexander Makatsaria, Russia

17:05

Selected Oral Communications

1)      Is a Pbac-Score a Good Tool to Quantify Menorrhagia in Women with Von Willebrand Disease and Rare Bleeding Disorders?; Halimeh S, Rott H; Germany

2)      rhuFVIIa in women with a refractory primary postpartum haemorrhage: an international, multicenter, randomised, opened, controlled trial; Lavigne-Lissalde G, Aya G, Mercier F, Roger-Christophe S, Chauleur C, Morau E, Ducloys A-S, Mignon A, Raucoule M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Castelli C, Fabbro-Perray P, Gris J-C; France & Switzerland

3)      Investigation of underlying platelet function defects in patients with unexplained menorrhagia; Lowe G, Lordkipanidzé M, Dawood B, Clark J, Lester W, Watson SP on behalf of the UK GAPP study; United Kingdom

20:00

FAREWELL DINNER (optional)

Sunday, February 3, 2013

08:30 – 10:00

VENOUS THROMBOEMBOLISM

Chairs: Gregoire Le Gal, Canada & Amparo Santamaria, Spain

08:30

Thrombosis during assisted reproduction

Scott M Nelson, United Kingdom

08:55

Cerebral vein thrombosis

Ida Martinelli, Italy

09:20

Pregnancy and travel-related thromboembolism

Suzanne C. Cannegieter, the Netherlands

09:45

Selected Oral Communications

1)      Pregnancy related thrombosis risk in patients with protein C deficiency; Rugeri L, Kouatra L, Arnuti B, Miranda P, Trzeciak MC, Vergnes C, Dargaud Y; France

2)      Venous thromboembolism after delivery: Trends in national readmission rates between 2002 and 2012; Lester W, Begaj I, Ray D, Pagano D; United Kingdom

3)      Differential risk factors for pregnancy-related deep vein thrombosis and pulmonary embolism – Results from a population-based case-control study; Bergrem A, Dahm AE.A., Jacobsen A-F, Sandvik L, Sandset PM; Norway

10:00

COFFEE BREAK

10:30 – 12:00

THROMBOSIS AND CANCER

Chairs: Per Morten Sandset, Norway & Armando D’Angelo, Italy

10:30

Epidemiology of cancer and thrombosis in women

Ingrid Pabinger, Austria

10:55

Mechanisms of thrombosis in cancer

Anna Falanga, Italy

11:20

International guidelines for anticoagulant management in cancer patients

Dominique Farge-Bancel, France

11:45

Selected Oral Communications

1)      Long-term mortality and incidence of cancer after pregnancy-related venous thrombosis (VT): results of a population-based, prospective cohort study; Wik HS, Jacobsen A-F, Wang Fagerland M, Sandvik L, Sandset PM; Norway

2)      The link between the hemostatic system and cancer: A genotype-phenotype study in breast cancer patients; Tinholt M, Viken MK, Børresen-Dale AL, Kristensen V, Kåresen R, Schlichting E, Garred Ø, Lie BA, Dahm AE, Skretting G, Sandset PM, Iversen N; Norway

12:00 – 13:50

LUNCH BREAK

12:30 – 13:50

LUNCH SYMPOSIUM

Thrombosis in Women

Chairs: Ian A. Greer, United Kingdom & Ida Martinelli, Italy

12:30

Introduction: Setting the stage

Ida Martinelli, Italy

12:35

Acute coronary syndrome: Are women appropriately taken care of?

Ariel Roguin, Israel

12:50

VTE prophylaxis in acutely ill medical patients: Should women be treated longer?

Jacqueline Conard, France

13:05

Gynecological cancer surgery – How long to treat?

Risto Kaaja, Finland

13:20

Bariatric surgery thromboprophylaxis in women

Emmanuel Papadakis, Greece

13:35

Round Table

13:50 - 15:20

NEW ANTICOAGULANTS

Chairs: Rupert M. Bauersachs, Germany & Marc Rodger, Canada

13:50

New anticoagulants in atrial fibrillation management

Sam Schulman, Canada

14:15

New anticoagulants in surgical patients

Walter Ageno, Italy

14:40

Thromboprophylaxis in cancer patients

Melina Verso, Italy

15:05

Selected Oral Communications

1)       Antithrombothic prophylaxis and ART procedures: an Italian  prospective cohort study; Grandone E, Villani M, Tiscia GL, Dentali F, Colaizzo D, Cappucci F, Fischetti L, Ageno W, Margaglione M; Italy

2)       Effects of LMWH prophylaxis on the morbidly obese pregnant women; Ismail SK, Norris L, O’Shea, Higgins JR; Ireland

15:20

15:30

Concluding Remarks: Ian A. Greer, United Kingdom; Benjamin Brenner, Israel

MEETING ADJOURNED